Biotech Firm Sees Option For Home Addiction Treatment Similar To Giving Insulin For Diabetes
Brady Granier, the CEO of California-based BioCorRx, says that he hopes to develop a low-dose, injectable-form of naltrexone that uses a small needle so that people could administer it at home.
Company Hopes To Make Addiction Treatment For Home Use
A California-based addiction treatment company hopes to change the way patients struggling with substance abuse disorder receive a popular form of medication-assisted treatment. If approved, patients could self-administer naltrexone, an opioid antagonist, in the comfort of their own homes — like insulin, but for recovering addicts. The promise of this advancement has some addiction experts excited about a product that could reduce the stigma surrounding recovery. Others, though, remain wary of moving such treatment out of a doctor’s office and away from wraparound services seen as essential for staying clean. (Blau, 4/28)